Antipyretic properties of some metabolic and structural analogues of sodium salicylate.
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001692:Biological Transport; D001812:Blood-Brain Barrier; D001831:Body Temperature; D002208:Caproates / Q000627:therapeutic use; D002552:Cerebral Ventricles; D004140:Dinitrophenols / Q000627:therapeutic use; D005334:Fever / Q000188:drug therapy*; D011817:Rabbits; D012457:Salicylamides / Q000627:therapeutic use; D012459:Salicylates / Q000378:metabolism / Q000627:therapeutic use*; D012980:Sodium Salicylate / Q000008:administration & dosage
D001565:Benzoates; D002208:Caproates; D004140:Dinitrophenols; D012457:Salicylamides; D012459:Salicylates; D001241:Aspirin; D012980:Sodium Salicylate